|
1
|
Kurian KC, Weisshaar D, Parekh H, Berry GJ
and Reitz B: Primary cardiac angiosarcoma: Case report and review
of the literature. Cardiovasc Pathol. 15:110–112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kupsky DF, Newman DB, Kumar G, Maleszewski
JJ, Edwards WD and Klarich KW: Echocardiographic features of
cardiac angiosarcomas: The mayo clinic experience (1976–2013).
Echocardiography. 33:186–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Araoz PA, Eklund HE, Welch TJ and Breen
JF: CT and MR imaging of primary cardiac malignancies.
Radiographics. 19:1421–1434. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Young RJ, Brown NJ, Reed MW, Hughes D and
Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–991. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prabu Ram MP, Thulkar S, Ray R and Bakhshi
S: Primary cardiac angiosarcoma with good response to Paclitaxel. J
Thorac Oncol. 6:1778–1779. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pigott C, Welker M, Khosla P and Higgins
RS: Improved outcome with multimodality therapy in primary cardiac
angiosarcoma. Nat Clin Pract Oncol. 5:112–115. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suderman D, Cooke A, Wong R and Klein J:
Treatment of cardiac angiosarcoma with radiation and docetaxel: A
case report with partial response and prolonged stable disease. J
Thorac Oncol. 6:834–835. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kodali D and Seetharaman K: Primary
cardiac angiosarcoma. Sarcoma. 2006:391302006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hata A, Katakami N, Fujita S, Kokubo M and
Imai Y: Angiosarcoma arising from right atrium: Remarkable response
to concurrent chemoradiotherapy with carboplatin and paclitaxel. J
Thorac Oncol. 6:970–971. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Franceschini D, Scotti V, Simontacchi G,
Meattini I, Paiar F, Greto D, Bonomo P, Franzese C, Di Cataldo V,
Pallotta S and Biti G: Application of helical tomotherapy for the
treatment of a right atrium angiosarcoma: A case report. Tumori.
99:e233–e236. 2013.PubMed/NCBI
|
|
11
|
Fehr M, Kuhn M, Mayer K, Padberg B, Ulmer
U and Cathomas R: Metastatic angiosarcoma arising from the right
atrium: Unusual presentation and excellent response to treatment in
a young patient. J Thorac Oncol. 5:1301–1302. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Castilla E, Pascual I, Roncalés F, Aguirre
E and Del Río A: Transient response of cardiac angiosarcoma to
paclitaxel. Eur J Cancer Care (Engl). 19:699–700. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Batzios S, Michalopoulos A, Kaklamanis L,
Stathopoulos J, Christopoulou M, Koutantos J and Stathopoulos GP:
Angiosarcoma of the heart: Case report and review of the
literature. Anticancer Res. 26:4837–4842. 2006.PubMed/NCBI
|
|
14
|
Aoka Y, Kamada T, Kawana M, Yamada Y,
Nishikawa T, Kasanuki H and Tsujii H: Primary cardiac angiosarcoma
treated with carbon-ion radiotherapy. Lancet Oncol. 5:636–638.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Elsayad K, Lehrich P, Yppaerilae-Wolters
H, Dieckmann C, Kriz J, Haverkamp U and Eich HT: Primary cardiac
angiosarcoma treated with positron emission tomography/magnetic
resonance imaging-guided adaptive radiotherapy. Can J Cardiol.
32:829.e7–829.e10. 2016. View Article : Google Scholar
|
|
16
|
Elsayad K, Scobioala S, Kriz J, Haverkamp
U and Eich HT: Advances in image-guided radiation therapy for
primary cardiac angiosarcoma: The role of PET-CT and MRI. Oncol Res
Treat. 39:290–294. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Penel N, Bui BN, Bay JO, Cupissol D,
Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S,
Jimenez M, et al: Phase II trial of weekly paclitaxel for
unresectable angiosarcoma: The ANGIOTAX study. J Clin Oncol.
26:5269–5274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anderson SE, Keohan ML, D'Adamo DR and
Maki RG: A retrospective analysis of vinorelbine chemotherapy for
patients with previously treated soft-tissue sarcomas. Sarcoma.
2006:159472006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dileo P, Morgan JA, Zahrieh D, Desai J,
Salesi JM, Harmon DC, Quigley MT, Polson K, Demetri GD and George
S: Gemcitabine and vinorelbine combination chemotherapy for
patients with advanced soft tissue sarcomas: Results of a phase II
trial. Cancer. 109:1863–1869. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Agulnik M, Yarber JL, Okuno SH, von Mehren
M, Jovanovic BD, Brockstein BE, Evens AM and Benjamin RS: An
open-label, multicenter, phase II study of bevacizumab for the
treatment of angiosarcoma and epithelioid hemangioendotheliomas.
Ann Oncol. 24:257–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang P, Zhu Q and Jiang F: Combination
therapy for scalp angiosarcoma using bevacizumab and chemotherapy:
A case report and review of literature. Chin J Cancer Res.
25:358–361. 2013.PubMed/NCBI
|
|
22
|
De Yao JT, Sun D, Powell AT and Rehmus EH:
Scalp angiosarcoma remission with bevacizumab and radiotherapy
without surgery: A case report and review of the literature.
Sarcoma. 2011:1603692011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koontz BF, Miles EF, Rubio MA, Madden JF,
Fisher SR, Scher RL and Brizel DM: Preoperative radiotherapy and
bevacizumab for angiosarcoma of the head and neck: Two case
studies. Head Neck. 30:262–266. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jeng MR, Fuh B, Blatt J, Gupta A, Merrow
AC, Hammill A and Adams D: Malignant transformation of infantile
hemangioma to angiosarcoma: Response to chemotherapy with
bevacizumab. Pediatr Blood Cancer. 61:2115–2117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nespereira-Jato MV, Peña-Panabad C,
Quindós-Varela M and García-Silva J: Unresectable angiosarcoma
treated with bevacizumab and paclitaxel. Actas Dermosifiliogr.
105:520–522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van der Graaf WT, Blay JY, Chawla SP, Kim
DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP,
Beppu Y, et al: Pazopanib for metastatic soft-tissue sarcoma
(PALETTE): A randomised, double-blind, placebo-controlled phase 3
trial. Lancet. 379:1879–1886. 2012. View Article : Google Scholar : PubMed/NCBI
|
